Synergistic effect of collagen and CXCL12 in the low doses on human platelet activation

PLoS One. 2020 Oct 29;15(10):e0241139. doi: 10.1371/journal.pone.0241139. eCollection 2020.

Abstract

CXCL12, also known as stromal cell-derived factor-1, is a chemokine classified into CXC families, which exerts its function by binding to specific receptors called CXCR4 and CXCR7. Human platelets express CXCR4 and CXCR7 on the plasma membrane. It has been reported that CXCL12 potentiates to induce platelet aggregation in cooperation with agonists including collagen. However, the precise roles and mechanisms of CXCL12 in human platelet activation are not fully elucidated. In the present study, we investigated the effect of simultaneous stimulation with low doses of collagen and CXCL12 on the activation of human platelets. The simultaneous stimulation with collagen and CXCL12 induced the secretion of platelet-derived growth factor (PDGF)-AB and the release of soluble CD40 ligand (sCD40L) from human platelets in addition to their aggregation, despite the fact that the simultaneous stimulation with thrombin receptor-activating peptide (TRAP) or adenosine diphosphate (ADP), and CXCL12 had little effects on the platelet aggregation. The agonist of Glycoprotein (GP) Ⅵ convulxin and CXCL12 also induced platelet aggregation synergistically. The monoclonal antibody against CXCR4 but not CXCR7 suppressed the platelet aggregation induced by simultaneous stimulation with collagen and CXCL12. The phosphorylation of p38 mitogen-activated protein kinase (MAPK), but not p44/p42 MAPK, was induced by the simultaneous stimulation. In addition, the simultaneous stimulation with collagen and CXCL12 induced the phosphorylation of HSP27 and the subsequent release of phosphorylated-HSP27 from human platelets. SB203580, a specific inhibitor of p38 MAPK, attenuated the platelet aggregation, the phosphorylation of p38 MAPK and HSP27, the PDGF-AB secretion, the sCD40L release and the phosphorylated-HSP27 release induced by the simultaneous stimulation with collagen and CXCL12. These results strongly suggest that collagen and CXCL12 in low doses synergistically act to induce PDGF-AB secretion, sCD40L release and phosphorylated-HSP27 release from activated human platelets via p38 MAPK activation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Blood Platelets / cytology
  • Blood Platelets / drug effects*
  • Blood Platelets / metabolism
  • CD40 Ligand / blood
  • Chemokine CXCL12 / pharmacology*
  • Collagen / pharmacology*
  • Healthy Volunteers
  • Heat-Shock Proteins / blood
  • Humans
  • Molecular Chaperones / blood
  • Platelet Activation / drug effects*
  • Platelet-Derived Growth Factor / metabolism
  • p38 Mitogen-Activated Protein Kinases / blood

Substances

  • CXCL12 protein, human
  • Chemokine CXCL12
  • HSPB1 protein, human
  • Heat-Shock Proteins
  • Molecular Chaperones
  • Platelet-Derived Growth Factor
  • platelet-derived growth factor AB
  • CD40 Ligand
  • Collagen
  • p38 Mitogen-Activated Protein Kinases

Grants and funding

This study was supported in part by the Research Funding for Longevity Sciences (28-9 and 19-21) from National Center for Geriatrics and Gerontology, Japan, https://www.ncgg.go.jp/english/index.html Funding acquisition: OK, HT The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.